Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  BG ControlType 1 DiabetesInsulinGlucose MonitoringIssue 681

Frequency of Blood Glucose Testing in Type 1's: How Often is Enough?

"Good diabetes control can be achieved in routine diabetes care with flexible intensified insulin therapy based on continuing patient education."...
Advertisement

As we know, self-monitored blood glucose (SMBG), as well as the knowledge of proper insulin use and requirements, is essential for proper metabolic control in patients with diabetes mellitus type 1. However, the question that this study tries to answer in particular is, what frequency of self monitoring of blood glucose is considered necessary for the most favorable glycemic control? 

This study focused especially on well-educated patients who understand the daily management of diabetes type 1 and the specific insulin requirements given. How often and to what extent SMBG should be executed on a daily basis remains unclear.

The study design used patients with type 1 diabetes and implemented a flexible and intensified insulin therapy. Intensive or flexible therapy involves using a constant supply of insulin to serve as the basalinsulin as well as providing mealtime insulin in doses relative to the nutritional load of the meals. Supplying extra insulin was also allowed when glucose levels were exceedingly high and in need of proper correction. These three components of the insulin regimen are commonly referred to as basal insulin, bolus insulin, and high glucose correction insulin methods.

Researchers evaluated HbA1c values and the directly preceding computerized SMBG-frequencies over a 12 month period. To approximate the relationship between HbA1c and SMBG-frequency the researchers used a fitted piecewise linear spline model with a change in slope at 4 SMBGs per day. The authors of the study recommended a minimal self monitoring blood glucose frequency of 4 times a day for best results.

The final study included a total of 150 patients who underwent the SMBG and HbA1c analysis. The study population used in the study had a median baseline HbA1c of 7.1% (interquartile range 6.6, 7.8). The final statistical assessment included a multivariable analysis which adjusted for gender and psychological problems. It was finally concluded that each added self monitoring blood glucose measurement by each patient was associated with an estimated difference in HbA1c of −0.19% (95% confidence interval (CI) −0.42, 0.05) for ≤4 SMBGs per day and of −0.02% (95% CI −0.10, 0.06) for >4 SMBGs per day.

What this statistical analysis ultimately illustrated was that optimal metabolic control was possible for diabetic type 1 patients with routine diabetes care, flexible and intensified insulin therapy coupled with continuing patient education and a minimum of 4 SMBGs checks per day.

A.Minder, D. Albrecht, J. Schäfer, and et al. "Frequency of blood glucose testing in well-educated patients with diabetes mellitus type 1: How often is enough?" Division of Endocrinology Diabetes and Metabolism, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.. Elsevier Ireland Ltd, 31 May 2013. Web. 4 Jun 2013.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 June, 2013 and appeared in  BG ControlType 1 DiabetesInsulinGlucose MonitoringIssue 681

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
A Telltale Sign of Type 2 Diabetes
Posted August 07, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: General Diabetes
Credits: .5